Major histocompatibility complex class III (C2, C4, factor B) and C3 gene variants in patients with pulmonary tuberculosis

Human Immunology

Volumn 72, Issue 2, 2011, Pages 173-178

  Senbagavalli, Prakash ^a   Kumar, Neeraj ^b   Kaur, Gurvinder ^b   Mehra, Narinder K ^b   Geetha, S T ^c   Ramanathan, Vadakkuppattu D ^a  

^a NATIONAL INSTITUTE FOR RESEARCH IN TUBERCULOSIS   (India)

^b ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^c Pulianthope ^*  (India)

Author keywords

Complement gene variants; Indian population; Innate immune system; Pulmonary tuberculosis

Indexed keywords

ALTERNATIVE COMPLEMENT PATHWAY C3 C5 CONVERTASE; COMPLEMENT COMPONENT C2; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 3;

ADULT; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HUMAN; IMMUNE RESPONSE GENE; INDIAN; INNATE IMMUNITY; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; PHENOTYPIC VARIATION; POPULATION GENETICS; PRIORITY JOURNAL;

ADULT; ALLELES; COMPLEMENT C2; COMPLEMENT C3; COMPLEMENT C4; COMPLEMENT FACTOR B; DNA FINGERPRINTING; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; HUMANS; INDIA; LINKAGE DISEQUILIBRIUM; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; PHENOTYPE; POLYMERASE CHAIN REACTION; RISK FACTORS; TUBERCULOSIS, PULMONARY;

EID: 78651258356     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2010.11.002     Document Type: Article

References (43)

1. Naik S. Can we look forward to genetic tests for tuberculosis susceptibility and severity?. Indian J Med Res 2006, 124:379-382.
2. Marquet S., Schurr E. Genetics of susceptibility to infectious diseases: Tuberculosis and leprosy as examples. Drug Metab Dispos 2001, 29:479-483.
3. Morgan B.P., Marchbank K.J., Longhi M.P., Harris C.L., Gallimore A.M. Complement: Central to innate immunity and bridging to adaptive responses. Immunol Lett 2005, 97:171-179.
4. Carter R.H., Fearon D.T. CD19: Lowering the threshold for antigen receptor stimulation of B lymphocytes. Science 1992, 256:105-107.
5. Reid R.R., Woodcock S., Shimabukuro-Vornhagen A., Austen W.G., Kobzik L., Zhang M., et al. Functional activity of natural antibody is altered in Cr2-deficient mice. J Immunol 2002, 169:5433-5440.
6. Fang Y., Xu C., Fu Y.X., Holers V.M., Molina H. Expression of complement receptors 1 and 2 on follicular dendritic cells is necessary for the generation of a strong antigen-specific IgG response. J Immunol 1998, 160:5273-5279.
7. Karp C.L., Wills-Karp M. Complement and IL-12: Yin and yang. Microbes Infect 2001, 3:109-119.
8. Morelli A.E., Larregina A.T., Shufesky W.J., Zahorchak A.F., Logar A.J., Papworth G.D., et al. Internalization of circulating apoptotic cells by splenic marginal zone dendritic cells: Dependence on complement receptors and effect on cytokine production. Blood 2003, 101:611-620.
9. Takahara M., Kang K., Liu L., Yoshida Y., McCormick T.S., Cooper K.D. iC3b arrests monocytic cell differentiation into CD1c-expressing dendritic cell precursors: A mechanism for transiently decreased dendritic cells in vivo after human skin injury by ultraviolet B. J Invest Dermatol 2003, 120:802-809.
10. Nauta A.J., Daha M.R., Tijsma O., van de Water B., Tedesco F., Roos A. The membrane attack complex of complement induces caspase activation and apoptosis. Eur J Immunol 2002, 32:783-792.
11. Uwai M., Terui Y., Mishima Y., Tomizuka H., Ikeda M., Itoh T., et al. A new apoptotic pathway for the complement factor B-derived fragment Bb. J Cell Physiol 2000, 185:280-292.
12. Maw W.W., Shimizu T., Sato K., Tomioka H. Further study on the roles of the effector molecules of immunosuppressive macrophages induced by mycobacterial infection in expression of their suppressor function against mitogen-stimulated T cell proliferation. Clin Exp Immunol 1997, 108:26-33.
13. Carroll M.C., Campbell R.D., Bentley D.R., Porter R.R. A molecular map of the human major histocompatibility complex class III region linking complement genes C4, C2 and factor B. Nature 1984, 307:237-241.
14. Yu C.Y., Belt K.T., Giles C.M., Campbell R.D., Porter R.R. Structural basis of the polymorphism of human complement components C4A and C4B: Gene size, reactivity and antigenicity. EMBO J 1986, 5:2873-2881.
15. Blanchong C.A., Zhou Bi, Rupert K.L., Chung E.K., Jones K.N., Sotos J.F., et al. Deficiencies of human complement component C4(A) and C4(B) and heterozygosity in length variants of RP-C4-CYP21-TNX (RCCX) modules in Caucasians: The load of RCCX genetic diversity on major histocompatibility complex-associated disease. J Exp Med 2000, 191:2183-2196.
16. Yang Y., Chung E.K., Wu Y.L., Savelli S.L., Nagaraja H.N., Zhou B., et al. Gene copy-number variation and associated polymorphisms of complement component C4 in human systemic lupus erythematosus (SLE): Low copy number is a risk factor for and high copy number is a protective factor against SLE susceptibility in European Americans. Am J Hum Genet 2007, 80:1037-1054.
17. Howard P.F., Hochberg M.C., Bias W.B., Arnett F.C., McLean R.H. Relationship between C4 null genes, HLA-D region antigens, and genetic susceptibility to systemic lupus erythematosus in Caucasian and black Americans. Am J Med 1986, 81:187-193.
18. Ruddy S. Component deficiencies. 3. The second component. Prog Allergy 1986, 39:250-266.
19. Alper C.A., Boenisch T., Watson L. Genetic polymorphism in human glycine-rich glycoprotein. J Exp Med 1972, 135:68-80.
20. Bentley D.R., Campbell R.D. C2 and factor B: Structure and genetics. Biochem Soc Symp 1986, 51:7-18.
21. Davrinche C., Abbal M., Clerc A. Molecular characterization of human complement factor B subtypes. Immunogenetics 1990, 32:309-312.
22. Arvilommi H. Capacity of complement C3 phenotypes to bind on to mononuclear cells in man. Nature 1974, 251:740-741.
23. Senbagavalli P., Geetha S.T., Karunakaran K., Banu Rekha v.v., Venkatesan P., Ramanathan V.S. reduced erythrocyte CR1 levels in patients with pulmonary tuberculosis is an acquired phenomenon. Clin Immunol 2008, 128:109-115.
24. Fitness J., Floyd S., Warndorff D.K., Sichali L., Malema S., Crampin A.C., et al. Large-scale candidate gene study of tuberculosis susceptibility in the Karonga district of northern Malawi. Am J Trop Med Hyg 2004, 71:341-349.
25. Leandro A.C., Rocha M.A., Cardoso C.S., Bonecini-Almeida M.G. Genetic polymorphisms in vitamin D receptor, vitamin D-binding protein, Toll-like receptor 2, nitric oxide synthase 2, and interferon-gamma genes and its association with susceptibility to tuberculosis. Braz J Med Biol Res 2009, 42:312-322.
26. Man X.Y., Luo H.R., Li X.P., Yao Y.G., Mao C.Z., Zhang Y.P. Polymerase chain reaction based C4AQ0 and C4BQ0 genotyping: Association with systemic lupus erythematosus in southwest Han Chinese. Ann Rheum Dis 2003, 62:71-73.
27. Barba G.M.R., Braun-Heimer L., Rittner C., Schneider P.M. A new PCR based typing of the Rodgers and Chido antigenic determinants of the fourth component of human complement. Eur J Immunogent 1994, 21:325-339.
28. Kumar N., Kaur G., Tandon N., Mehra N.K. Allotyping human complement factor B in Asian Indian type 1 diabetic patients. Tissue Antigens 2008, 72:517-524.
29. Tang S., Zhou W., Sheerin N.S., Vaughan R.W., Sacks S.H. Contribution of renal secreted complement C3 to the circulating pool in humans. J Immunol 1999, 162:4336-4341.
30. Selvaraj P. Role of human leukocyte antigen (HLA) and non-HLA genes in susceptibility or resistance to pulmonary tuberculosis. Ind J Tub 2000, 47:133-138.
31. Johnson C.A., Densen P., Hurford R.K., Colten H.R., Wetsel R.A. Type I human complement C2 deficiency. A 28-base pair gene deletion causes skipping of exon 6 during RNA splicing. J Biol Chem 1992, 2267:9347-9353.
32. Kay P.H., Natsuume-Sakai S., Hayakawa J., Dawkins R.L. Different allotypes of C3 degrade at different rates. Immunogenetics 1985, 22:563-569.
33. Finn J.E., Zhang L., Agrawal S., Jayne D.R., Oliveira D.B., Mathieson P.W. Molecular analysis of C3 allotypes in patients with systemic vasculitis. Nephrol Dial Transplant 1994, 9:1564-1567.
34. Finn J.E., Mathieson P.W. Molecular analysis of C3 allotypes in patients with nephritic factor. Clin Exp Immunol 1993, 91:410-414.
35. Hasegawa K., Tamari M., Shao C., Shimizu M., Takahashi N., Mao X.Q., et al. Variations in the C3, C3a receptor, and C5 genes affect susceptibility to bronchial asthma. Hum Genet 2004, 115:295-301.
36. Lokki M.-L., Koskimies S.A. Allelic differences in hemolytic activity and protein concentration of BF molecules are found in association with particular HLA haplotypes. Immunogenetics 1991, 134:242-246.
37. Horiuchi T., Kim S., Matsumoto M., Watanabe I., Fujita S., Volanakis J.E. Human complement factor B: cDNA cloning, nucleotide sequencing, phenotypic conversion by site-directed mutagenesis and expression. Mol Immunol 1993, 30:1587-1592.
38. Rambausek M., van den Wall Bake A.W., Schumacher-Ach R., Spitzenberg R., Rother U., van Es L.A., et al. Genetic polymorphism of C3 and Bf in IgA nephropathy. Nephrol Dial Transplant 1987, 2:208-211.
39. Messias-Reason I.J., Urbanetz L., Pereira da Cunha C. Complement C3 F and BF S allotypes are risk factors for Chagas disease cardiomyopathy. Tissue Antigens 2003, 62:308-312.
40. Kaur G., Kumar N., Szilagyi A., Blasko Bernadett F.G., Rajczy K., et al. The European AH8.1 and Asian Indian HLA-B8-DR3 recombinant haplotypes differ in C4A and C4B gene copy numbers and other central MHC polymorphisms. Hum Immunol 2008, 69:580-587.
41. Ad'Hiah A.H., Papiha S.S. Complement components C2, C3, and C4 (C4A and C4B) and BF polymorphisms in populations of the Indian subcontinent. Hum Biol 1996, 68:755-776.
42. Hartung K., Baur M.P., Coldewey R., Fricke M., Kalden J.R., Lakomek H.J., et al. Major histocompatibility complex haplotypes and complement C4 alleles in systemic lupus erythematosus. Results of a multicenter study. J Clin Invest 1992, 90:1346-1351.
43. Jackson C.G., Ochs H.D., Wedgwood R.J. Immune response of a patient with deficiency of the fourth component of complement and systemic lupus erythematosus. N Engl J Med 1979, 300:1124-1129.